Stratec (ETR:SBS) Shares Up 5.1% – Time to Buy?

Stratec SE (ETR:SBSGet Free Report)’s share price traded up 5.1% during mid-day trading on Friday . The company traded as high as €35.25 ($37.11) and last traded at €34.15 ($35.95). 14,984 shares changed hands during trading, an increase of 140% from the average session volume of 6,253 shares. The stock had previously closed at €32.50 ($34.21).

Stratec Stock Performance

The company has a market cap of $407.97 million, a price-to-earnings ratio of 28.19, a P/E/G ratio of 10.43 and a beta of 0.16. The company has a debt-to-equity ratio of 65.99, a current ratio of 2.47 and a quick ratio of 1.65. The firm has a fifty day simple moving average of €34.27 and a 200 day simple moving average of €40.41.

Stratec Company Profile

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Featured Articles

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.